"Zyn is just a recent iteration of the tobacco industry’s historical practice of designing a nicotine delivery device that ...
The Food and Drug Administration on Friday issued marketing granted orders to six On Plus nicotine pouch products. They are the first authorizations under a pilot program launched in September to ...
Survey adds to experts’ concern about addiction risk and highlights support for plan to ban sales to under-18s ...
Altria edged higher in Monday trading as investors reacted to the FDA decision on December 19 to issue Marketing Granted ...
The Food and Drug Administration cleared on! Plus nicotine pouches to be sold in the U.S. market, the first authorization under a government program to expedite regulatory approvals for certain ...
C-store retailers navigate tobacco and nicotine category with new authorizations, higher state excise taxes and record ...
The U.S. Food and Drug Administration (FDA) has authorized the marketing of six on! PLUS nicotine pouch products owned by ...
Philip Morris Limited (PML), the UK and Ireland affiliate of Philip Morris International (PMI), has announced a new campaign, highlighting ZYN X-Low (1.5mg), ...
The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine ...
The recent announcement by Philip Morris International that it is partnering with Ferrari to market its Zyn nicotine pouches on Formula 1 race cars shows the company is blowing smoke when it claims ...
The video revealed how Zyn exploded across the world and quietly built a new wave of nicotine addiction. It showed how ...
Zacks Investment Research on MSN
Altria vs. Philip Morris: Who leads tobacco's next chapter?
Altria Group, Inc. (MO) and Philip Morris International Inc. (PM) rank among the most influential players in the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results